Dual role of IL-12 in the therapeutic efficacy or failure during combined PEG-Interferon-alpha 2A and ribavirin therapy in patients with chronic hepatitis C

Files in this item

This item appears in the following Collection(s)

Search DSpace



Browse

My Account

Statistics